Reduction of the dislocated hips with the Tübingen hip flexion splint in infants

Murat Yegen1, Hakan Atalar2, Cuneyd Gunay3

  • 1Department of Orthopaedics and Traumatology, Ankara Onkoloji Research and Training Hospital, Ankara, Turkey.

International Orthopaedics
|November 29, 2018
PubMed

Insights

The Tübingen hip flexion splint effectively treats dislocated hips (Graf types D, 3, and 4) in infants. Early treatment, ideally before 15 weeks, significantly improves success rates for developmental dysplasia of the hip.

Area of Science:

  • Orthopedics
  • Pediatric Medicine
  • Radiology

Background:

  • Developmental dysplasia of the hip (DDH) requires early detection and conservative management for optimal outcomes.
  • Ultrasonography, particularly the Graf classification, is crucial for diagnosing hip dislocation severity.

Purpose of the Study:

  • To assess the effectiveness of the Tübingen hip flexion splint for treating dislocated hips classified as Graf type D, 3, and 4.
  • To identify factors influencing treatment success with the Tübingen splint.

Main Methods:

  • 104 dislocated hips in 92 patients diagnosed via ultrasonography were treated with Tübingen splints.
  • Hips were reassessed using Graf classification after 4-6 weeks of splinting.
  • Treatment success was defined by upgrading of Graf classification post-splinting.

Main Results:

  • The mean age at treatment initiation was 11.9 weeks.
  • No significant correlation was found between success rates and sex or bilateral involvement.
  • Age at treatment initiation was a significant factor (p=0.03) for successful splinting.

Conclusions:

  • The Tübingen splint demonstrated a 75% success rate in treating Graf type D, 3, and 4 dislocated hips.
  • Initiating Tübingen splint treatment before 15 weeks of age is associated with higher success rates (84.62% sensitivity).
  • The Tübingen hip flexion splint is a viable conservative treatment option for specific types of infantile hip dislocation.
Abstract

Related Concept Videos

Oxidation-Reduction Reactions03:11

Oxidation-Reduction Reactions

Oxidation–Reduction Reactions
75.7K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
295
Oxymercuration-Reduction of Alkenes02:36

Oxymercuration-Reduction of Alkenes

Oxymercuration–reduction of alkenes is one of the major reactions converting alkenes to alcohols. It involves the hydration of alkenes with mercuric acetate in a mixture of tetrahydrofuran and water, forming an organomercury adduct. This is followed by a demercuration step in which the adduct is reduced to an alcohol using sodium borohydride.
9.4K
Block Diagram Reduction01:22

Block Diagram Reduction

The process of deriving the transfer function of a control system often involves reducing its block diagram to a single block. This simplification can be achieved through a series of strategic operations, including relocating branch points and comparators. These operations preserve the overall function of the system while allowing for easier manipulation and combination of blocks.
The first step in this process is the identification and relocation of a branch point. A branch point, where a...
561
Phase I Reactions: Reductive Reactions01:27

Phase I Reactions: Reductive Reactions

Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
595
Esters to Alcohols: Hydride Reductions01:17

Esters to Alcohols: Hydride Reductions

Esters are reduced to primary alcohols when treated with a strong reducing agent like lithium aluminum hydride. The reaction requires two equivalents of the reducing agent and proceeds via an aldehyde intermediate.
Lithium aluminum hydride is a source of hydride ions and functions as a nucleophile. The mechanism proceeds in three steps. Firstly, the nucleophilic hydride ion attacks the carbonyl carbon of the ester to form a tetrahedral intermediate. Subsequently, the carbonyl group re-forms,...
4.8K